|
|
Volumn 39, Issue SUPPL. 3, 2007, Pages
|
|
Therapy of chronic hepatitis B: focus on telbivudine
|
|
Author keywords
Chronic hepatitis B; Interferon; Necroinflammation; Telbivudine
|
|
Indexed keywords
ADEFOVIR;
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
ENTECAVIR;
HEPATITIS B(E) ANTIGEN;
INTERFERON;
LAMIVUDINE;
NUCLEOSIDE ANALOG;
NUCLEOTIDE DERIVATIVE;
PEGINTERFERON ALPHA2A;
TELBIVUDINE;
VIRUS DNA;
CLINICAL TRIAL;
COMORBIDITY;
DRUG APPROVAL;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
EUROPE;
GENOTYPE;
HEPATITIS B;
HUMAN;
LIVER CELL CARCINOMA;
MITOCHONDRIAL TOXICITY;
PROGNOSIS;
REVIEW;
TREATMENT DURATION;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
VIRUS LOAD;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
DNA, VIRAL;
HEPATITIS B, CHRONIC;
HUMANS;
NUCLEOSIDES;
PYRIMIDINONES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
VIRAL LOAD;
|
|
EID: 36549070632
PISSN: 15908658
EISSN: None
Source Type: Journal
DOI: 10.1016/S1590-8658(07)60017-6 Document Type: Review |
|
Times cited : (12)
|
|
References (0)
|
